MIND4-19（Cat No.:I043426）is a small-molecule inhibitor that targets the mitotic kinase, Mps1, which plays a crucial role in the spindle assembly checkpoint during cell division. By inhibiting Mps1, MIND4-19 disrupts the proper alignment and segregation of chromosomes during mitosis, leading to mitotic defects and cell death, particularly in cancer cells. Its selective mechanism offers potential for targeted cancer therapies, particularly for tumors with abnormal mitotic checkpoint regulation. MIND4-19 is being explored as a tool for studying mitotic control and as a therapeutic agent in cancer treatment, particularly in spindle checkpoint-targeted therapies.